Integra Lifesciences 

$11.11
0
-$0.27-2.37% Today

Statistics

Day High
11.18
Day Low
10.86
52W High
-
52W Low
-
Volume
7,378
Avg. Volume
-
Mkt Cap
865.38M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25FebExpected
Q3 2025
Next
0.43
0.56
0.68
0.8
Expected EPS
0.800189
Actual EPS
N/A

Financials

-0.43%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
3.22BRevenue
-13.89MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IART.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation competes directly with Integra Lifesciences in the medical technology and surgical instruments sector, offering similar products for neurosurgery and orthopedics.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers a wide range of medical devices that compete with Integra's offerings, especially in the neurosurgery and spinal products market.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices segment, competes in various areas including surgical products and wound care, overlapping with Integra's product lines.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the orthopedic and neurosurgery sectors, offering products that directly compete with Integra's surgical instruments and implants.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation offers products in the neuromodulation and neurovascular sectors, competing with Integra Lifesciences' neurosurgical product lines.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spinal and orthopedic surgery products, competing with Integra's offerings.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra Lifesciences competes with itself through its diverse range of products, constantly innovating and expanding its portfolio to stay competitive in the market.
Alphatec
ATEC
Mkt Cap2.87B
Alphatec Holdings, Inc. is a provider of spinal surgery solutions, competing in the same space as Integra Lifesciences with its focus on innovative spinal products and technologies.

About

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Show more...
CEO
Dr. Stuart M. Essig Ph.D.
Employees
4396
Country
US
ISIN
US4579852082

Listings

0 Comments

Share your thoughts

FAQ

What is Integra Lifesciences stock price today?
The current price of IART.BOATS is $11.11 USD — it has decreased by -2.37% in the past 24 hours. Watch Integra Lifesciences stock price performance more closely on the chart.
What is Integra Lifesciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Integra Lifesciences stocks are traded under the ticker IART.BOATS.
What is Integra Lifesciences market cap?
Today Integra Lifesciences has the market capitalization of 865.38M
When is the next Integra Lifesciences earnings date?
Integra Lifesciences is going to release the next earnings report on February 25, 2026.
What were Integra Lifesciences earnings last quarter?
IART.BOATS earnings for the last quarter are 0.54 USD per share, whereas the estimation was 0.43 USD resulting in a +24.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Integra Lifesciences revenue for the last year?
Integra Lifesciences revenue for the last year amounts to 3.22B USD.
What is Integra Lifesciences net income for the last year?
IART.BOATS net income for the last year is -13.89M USD.
How many employees does Integra Lifesciences have?
As of February 02, 2026, the company has 4,396 employees.
In which sector is Integra Lifesciences located?
Integra Lifesciences operates in the Health Care sector.
When did Integra Lifesciences complete a stock split?
Integra Lifesciences has not had any recent stock splits.
Where is Integra Lifesciences headquartered?
Integra Lifesciences is headquartered in Princeton, US.